BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  Capricor Therapeutics, Inc. Announces Plans To Expand Clinical Development Program In Duchenne Muscular Dystrophy To Evaluate Peripheral And Respiratory Muscle Function

  November 11, 2016

   · 

  7 min read
• Business

  Syndax Reports Third Quarter 2016 Financial Results And Provides Business Update

  November 11, 2016

   · 

  1 min read
• Business

  Collegium Reports Third Quarter Financial Results and Provides Corporate Update

  November 11, 2016

   · 

  1 min read
• Drug Development

  Regeneron And Sanofi To Present Data From Phase 3 Praluent (Alirocumab) Injection Clinical Trials At AHA Scientific Sessions 2016

  November 11, 2016

   · 

  13 min read
• Drug Development

  Compugen Ltd. Immune Checkpoint Program Demonstrates Potential For Development Of New Cancer Immunotherapy Treatments

  November 11, 2016

   · 

  4 min read
• Drug Development

  Alexion Release: New Long-Term Data Presented At American Association for Study of Liver Diseases Show Reduction In Liver Fibrosis And Cirrhosis In A Cohort Of Patients With Lysosomal Acid Lipase Deficiency (LAL-D) Treated With Kanuma (Sebelipase Alfa)

  November 11, 2016

   · 

  14 min read
• Drug Development

  Pulse Biosciences Announces New Data That Reinforce Potential Immuno-Oncology Benefits Of Nano-Pulse Stimulation Technology

  November 11, 2016

   · 

  5 min read
• Biotech Bay

  European CHMP Adopts Positive Opinion For Gilead’s Vemlidy (Tenofovir Alafenamide, TAF) For The Treatment Of Chronic Hepatitis B Virus Infection

  November 11, 2016

   · 

  3 min read
• Drug Development

  Atreca Presents Promising Findings From Lead Antibody Program At Society For Immunotherapy Of Cancer (SITC) Annual Meeting

  November 11, 2016

   · 

  3 min read
• Drug Development

  Boehringer Ingelheim Release: Patient Enrollment Completed For RE-DUAL PCI Study Assessing Dabigatran In Atrial Fibrillation Patients After PCI With Stenting

  November 11, 2016

   · 

  3 min read